Managing Excessive Daytime Sleepiness

Non-Pharmacological Approaches

The American Geriatrics Society recommends maintaining stable bedtimes and wake times, even on weekends, to help manage excessive daytime sleepiness, and creating a restful and comfortable bedroom environment to improve sleep quality 1
Avoiding sleep-fragmenting substances such as caffeine, nicotine, and alcohol, and avoiding heavy exercise within 2 hours of bedtime is suggested to promote better sleep 1
Using the bedroom only for sleep and sex, and avoiding activities like watching TV or working, is recommended to improve sleep hygiene, and limiting daytime napping to 30 minutes and avoiding napping after 2 PM is advised to minimize interference with nighttime sleep 1
Creating a 30-minute relaxation period before bedtime and considering a hot bath 90 minutes before bedtime is recommended to improve sleep quality 1
Implementing good sleep hygiene practices, including a regular sleep-wake schedule, adequate time for nocturnal sleep, and avoiding heavy meals and alcohol, is recommended for patients with excessive daytime sleepiness 1
Scheduling two 15-20 minute naps daily (at noon and 4-5 pm) and increasing daytime physical activity can help manage excessive daytime sleepiness 1

Medications like modafinil may be considered when non-pharmacological approaches are insufficient, starting at the lowest available doses and monitoring for side effects, as recommended by the American Geriatrics Society 1
The American Geriatrics Society recommends using validated questionnaires like Epworth Sleepiness Scale (ESS) to quantify sleepiness severity in patients with excessive daytime sleepiness, and evaluation for underlying causes of excessive daytime sleepiness should include assessment for sleep deprivation, sedating medications, medical conditions, neurologic disorders, and psychiatric conditions 1
Modafinil is recommended as a first-line treatment for most cases of central hypersomnias, with dosing starting at 100 mg upon awakening and increasing weekly as needed to 200-400 mg daily, while sodium oxybate is recommended as a first-line treatment for narcolepsy, administered as a liquid in 2 divided doses (at bedtime and 2.5-4 hours later) 1, 2
Traditional stimulants (such as methylphenidate and amphetamines) may be considered as second-line treatments for excessive daytime sleepiness when modafinil is ineffective, but they carry a higher risk of cardiovascular side effects and dependence, and patients with cardiovascular disease should avoid stimulants 1

Overnight polysomnography (PSG) followed by Multiple Sleep Latency Test (MSLT) is recommended for suspected central hypersomnias, with a mean sleep latency ≤8 minutes with ≥2 REM sleep episodes on MSLT suggesting narcolepsy 1
Brain MRI is recommended if a neurologic cause is suspected (tumors, MS, stroke), and laboratory tests such as TSH, liver function, CBC, and basic chemistry should be conducted 1

More frequent follow-up is recommended when starting or adjusting medications, with monitoring for adverse effects, treatment efficacy using ESS, and functional ability improvements, and assessing the need for occupational accommodations is also recommended 1
Patients with excessive daytime sleepiness should be advised to avoid shift work, on-call schedules, driving or operating heavy machinery until symptoms are controlled, and jobs requiring sustained attention without breaks 1
Patients with suspected narcolepsy or idiopathic hypersomnia, unknown cause of sleepiness, or complex cases unresponsive to initial therapy may require referral to a specialist 1

Failing to identify and treat underlying sleep disorders (especially sleep apnea) can have significant consequences for patients with excessive daytime sleepiness, and inadequate treatment of cataplexy when present, overlooking drug interactions with sodium oxybate and CNS depressants, and insufficient monitoring of treatment response and side effects can also have negative consequences 2, 1